
We are still recruiting! Please share the word 🩵 #diabetes #DiabetesAwareness #research #WorldDiabetesDay2026
✓Type 1 diabetes immunologist focusing on improving the lives of those living with, or at risk of, Type 1 diabetes

We are still recruiting! Please share the word 🩵 #diabetes #DiabetesAwareness #research #WorldDiabetesDay2026


For #wdd2026, we asked our ELSA families what a 2-3 year delay to T1D would mean to them. Here's what they said... Thank you to our funders: @BT1DUK @DUK_research @unibirmingham @parthnarendran @RenukaDias @Dr_LaurenQuinn #WorldDiabetesDay2026 #WorldDiabetesDay

the ELSA team have a world diabetes awareness' stand at QE-UHB in the main atrium tomorrow. Pass by and say hello and meet the team #T1D @uhbtrust @UHBEducation @UHBLeadership @parthnarendran @JAPearsonLab @RenukaDias 💊🩸🔬🧬🧫

So proud of the diabetes team here @unibirmingham and @CQehb for getting everything together to administer Teplizumab to the first person on the NHS. This has taken years with lots of international collaborative working to become a reality.


🚨 We are hiring! We have TWO postdoctoral positions and one Research Associate position to join our team. Deadlines to apply is Nov15-22. Please see our website for details and how to apply: theradlab.co.uk/vacancies

Come and join us on World Diabetes Day Saturday 14th November to learn more about the diabetes research we are doing at University of Birmingham and see how you can get involved! #research #Birmingham #diabetes #diabetesawarenessmonth

We still have 2 places left in our “SMART” study if you have type 1 diabetes and are aged 18-50! See below for a full list of research opportunities…

Learn all about how we developed an interactive research activity and in person research event with young people living with T1D with the help of @britsocimm, @BT1DUK, @BioRadEducation kits, the Steve Morgan Foundation, and a team of fantastic people! immunology.org/news/cardiff-…

Could the next generation of type 1 diabetes treatments come from better timing, better combinations, or better cells? Across the UK, researchers are working together in the #Type1DiabetesGrandChallenge to find answers. They're asking: - Could the time of day an immunotherapy is given make it more effective at slowing the immune attack? - Could combining immunotherapies, to target different parts of the immune system, provide better protection for insulin-producing cells? - How can we strengthen insulin-producing cells before transplantation so they're more likely to survive in the body? Mollie Hillis travelled from Birmingham to Edinburgh to meet the teams behind this research and discover how collaboration is accelerating progress towards new treatments. Because answering big questions takes big ideas - and, importantly, people working together. Read more: bit.ly/4yeq7qN #T1D #GBDoc #Research @DiabetesUK

Does your family plan on joining us at our Discovery Day in London next Saturday? We'd love to hear from you! 👂 We're looking for families to join us for a quick and informal session, to help us understand the information and support that were most useful to you since diagnosis. Your opinion will help us shape and improve the support we give to newly diagnosed families. 💙 We're incredibly thankful to The Bukhman Foundation for supporting our Community Engagement work! Tap the link and sign up today: bit.ly/3UUYNiB 🔗 #DiscoveryDay #GBDoc #BreakthroughT1D

We are recruiting three volunteers for the Scientific Advisory Council (SAC)🚨 The purpose of the SAC is to provide insightful, independent advice and critical opinions to Breakthrough T1D by guiding our research decisions, policies and position statements. We are looking for: - One expert by experience (18-22 y/o) - One healthcare professional (dietitian) - One clinical researcher Find out more about these roles: bit.ly/4cB3xQk 🔗

Could the time an immunotherapy treatment is given make it more effective for people with type 1 diabetes? That's the question Dr James Pearson and his team are exploring. Their research is investigating whether delivering treatment when protective immune cells (Tregs) are most 'awake' could improve its ability to slow or prevent the immune system from attacking insulin-producing cells. It's an innovative approach that could help unlock more effective immunotherapies for type 1 diabetes. Read more about the project here: bit.ly/49w2flG @DiabetesUK #Type1Diabetes #GBDoc #Type1DiabetesGrandChallenge

BCHC Community Connexions. We remain deeply appreciative of the £2,000 contribution received, from The ELSA study @elsadiabetes who had taken on fundraising challenges, which will support @BCHC_CommCX in organising approximately 2–3 further Community Clinics.

Meet the team behind the ELSA study: Consultant receives national recognition for leading pioneering T1D research @uhbtrust @unibirmingham @parthnarendran @RenukaDias @JAPearsonLab uhb.nhs.uk/news-and-events/n…